Hepatocellular carcinoma (HCC) is a type of liver cancer that is notoriously tough to treat. Doctors have been experimenting with immune checkpoint inhibitors (ICIs) to fight this disease. However, these drugs can sometimes make the cancer grow faster, a condition known as hyperprogressive disease (HPD). This is bad news for patients, as it means the cancer is gettin...
Liver cancer, specifically hepatocellular carcinoma (HCC), is a serious issue. It's the most common type of liver cancer and a major cause of cancer deaths around the world. One of the scary things about HCC is that it can spread both inside and outside the liver. This spreading, or metastasis, is a big part of what makes liver cancer so dangerous. Scientists have b...
Think about liver cancer, or hepatocellular carcinoma (HCC), it's a tough opponent. But what if we could team up two powerful treatments to fight it? That's exactly what a recent study did. They combined transarterial chemoembolization (TACE) with lenvatinib, a targeted therapy. The results? A significant boost in effectiveness. First, let's break down what each tre...
Liver cancer, or hepatocellular carcinoma (HCC), is a major cause of cancer deaths worldwide. One surprising factor that can contribute to its development is a tiny parasite called Clonorchis sinensis. This parasite is known to cause liver infections, but its exact role in cancer progression is still a mystery. Researchers have been trying to figure out how ...
Liver cancer, also known as hepatocellular carcinoma (HCC), is a serious disease. It is often life-threatening. However, some people beat the odds. They live for more than 5 years after diagnosis. This is a big deal. It's important to understand their journey. It can help doctors and patients. It can also help us understand the disease better. A study looked ...
Thepast couple of decades have been a troubling timeline for liver diseases and cancer related to them. This has many scientists wondering what is going on , a common suspect is the lifestyle choices. Researchers are investigating if our parents drinking alcoholic beverages can increase the risk of liver diseases and cancer of liver cells in the future and do...
Imagine you're trying to understand how your body's immune system affects liver cancer. It's a complex puzzle, right? Researchers have been studying the tiny immune cells that live near liver tumors. These cells play a big role in how cancer grows and how well treatments work. Scientists looked at a bunch of liver cancer samples from different databases and real-lif...
Ever wondered how cancer cells trick the immune system into turning a blind eye? Well, there's an enzyme called Deltex E3 ubiquitin ligase 2, or DTX2, that does just that in liver cancer. Scientists found out that this enzyme helps cancer cells in the liver attract certain immune cells called neutrophils, which then act as shields for the cancer cells. These neutroph...
When it comes to treating unresectable hepatocellular carcinoma (uHCC), a type of liver cancer, lenvatinib is often the go-to treatment. But how does it stack up against other options? Researchers used a clever method called inverse probability of treatment weighting (IPTW) and network meta-analysis (NMA) to compare lenvatinib with other treatments that are either ap...
Imagine you could predict if someone with chronic liver disease might develop liver cancer using a simple, non-invasive test. That's what researchers set out to do. They focused on a method called vibration-controlled transient elastography (VCTE), which measures liver stiffness to gauge fibrosis. The goal? To create a universal risk score that could forecast hepatoc...